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Background
The purpose of our study is to determine the role of growth
factors (GF) in the process of pleurodesis. Biochemical
characteristics of the pleural effusion (PE) are an important
prognostic factor. Published data on the role of GF in
the formation of PE and its treatment is somewhat
contradictory.
Methods
A prospective randomized study included 40 female
patients with malignant PE resulting from breast carci-
noma. They were divided into two groups and treated by
means of mechanical (MP) or chemical (CP) pleurodesis.
Samples of pleural fluid were analyzed by ELISA. The
study was approved by the National Ethics Committee.
Results
We found a 2.5 times increase in VEGF levels in
the serum when performing a CP and a less than
25% increase of its original value in MP group. The aver-
age serum level of VEGF before receiving CP was
458.65 ng/ml (172-702 ng/ml) and was elevated to a
mean level of 1197.65ng/ml (406-2011ng/ml). In the
MP group same results for serum VEGF were found
517.55 ng/ml (73-976 ng/ml) and 632.24 ng/ml (111 –
1136 ng/ml). Peak levels were noted between 24 and
48 hours after performing pleurodesis.
Of the GF secreted, particularly VEGF was present in
excess. Serum VEGF could be the cause of some of the
side effects we are faced with when performing CP.
The relationship between the released GF in MP is
somewhat different. Namely, it has less influence on
serum VEGF levels. We also believe that a proteoglycan
bound FGF which is found in basal membrane might be
the key to an effective pleurodesis.
Conclusions
It is important to understand that the current knowledge
of the effects of GF combined with our findings represents
a contraindication for CP. Excess concentration of VEGF
creates an environment that promotes the formation of
PE, growth of tumor tissue and acts as a mediator of
inflammation, possibly resulting in ARDS. We propose to
use the MP as an effective, harmless and inexpensive
method.
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